The evolution of clinical trials in response to COVID-19.

Sarah, Alana; Dean, Olivia; Berk, Michael

Sarah, Alana; Dean, Olivia; Berk, Michael.

Sarah A; University Hospital Geelong, Barwon Health, Geelong, VIC.
Dean O; University Hospital Geelong, Barwon Health, Geelong, VIC.
Berk M; Institute for Physical and Mental Health and Clinical Translation, Barwon Health, Deakin University, Geelong, VIC.

Med J Aust ; 214(7): 332-332.e1, 2021 04.

Article in English | MEDLINE | ID: covidwho-1145684

Subject(s)

COVID-19/prevention & control; COVID-19/therapy; Clinical Trials as Topic; COVID-19/epidemiology; COVID-19 Vaccines; Humans; Pandemics; Research Design/trends; SARS-CoV-2

Keywords

COVID-19; Clinical trials as topic; Infectious diseases; Respiratory tract infections

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Med J Aust Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google